Tenon Medical (NASDAQ:TNON) Q1 Revenue Surges 90% as Gross Margin Expands, Loss Narrows
Transcript: Tenon Medical Q1 2026 Earnings Conference Call
Tenon Medical Q1 EPS $(0.31) Misses $(0.30) Estimate, Sales $1.379M Beat $1.296M Estimate.
Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings
Tenon Medical's CATAMARAN SI Joint Fusion System Receives FDA 510(k) Clearance As Substantially Equivalent Orthopedic Device
Tenon Medical Inc (TNON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Tenon Medical, Inc. Q4 2025 Earnings Call Summary
Tenon Medical (TNON) Q4 2025 Earnings Transcript
Tenon Medical Inc. (NASDAQ:TNON) Reports Strong Q4 2025 Revenue Growth and FDA Clearance for SImmetry®+
Tenon(R) Medical Reports Fourth Quarter and Full Year 2025 Financial Results
Tenon Medical Q4 EPS $(0.22) Beats $(0.36) Estimate, Sales $1.500M Beat $1.379M Estimate
WallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 Million
Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million
Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion
Tenon Medical Expands U.S. IP Portfolio With USPTO Notices Of Allowance For Multiple Patents Expected In 2026
Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues
Tenon(R) Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025
Tenon Medical Reports Preliminary Q4 Revenue Of ~$1.45M - $1.48M, FY25 Revenue ~$3.91M To $3.94M
Tenon Medical Announces Successful Completion of Initial Cases with New SImmetry(R)+ SI Joint Fusion System
Tenon Medical Completes First Procedures Using New SImmetry+ SI Joint Fusion System
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.